Why the Menopause Physical Exam Matters More Than Most Women Realize
The menopause physical exam is not a routine gynecologic checkup. It is a targeted evaluation designed to assess where you are in the menopausal transition, quantify your symptom burden, identify conditions that mimic or worsen menopause symptoms, and establish baseline measurements for monitoring treatment. Most women approach this visit expecting a 10-minute prescription pad encounter. A proper menopause visit takes 30 to 60 minutes and covers at least four distinct areas: symptom history, physical examination, lab testing, and bone density assessment. Anything less is not an adequate menopause evaluation, and accepting less from your doctor means you are not getting the full picture.
The problem is that most ob-gyn visits do not meet this standard. A 2025 survey in Menopause found that the average duration of a US ob-gyn visit was 16 minutes, and only 23 percent of that time was spent on menopause-specific discussion. The rest went to cervical cancer screening discussion, blood pressure checks, and administrative tasks. If your menopause appointment feels rushed, it is not because a longer visit is unnecessary — it is because the healthcare system does not reimburse adequately for complex perimenopausal or menopausal care. Knowing what a proper exam should include helps you advocate for the time and attention your health deserves.
Preparing for the visit cuts the wasted time in half. The NAMS menopause visit checklist recommends bringing three things: a two-week symptom diary with hot flash and night sweat counts, a complete list of medications and supplements, and your family medical history for breast cancer, ovarian cancer, osteoporosis, and heart disease. Women who bring these documents average 12 more minutes of clinical discussion time than those who do not, according to a 2024 University of Michigan study of 340 first-time menopause visits. The menopause treatment approach that works starts with a proper baseline, and that baseline is the physical exam.
What Happens During the Physical Exam Part of Your Visit
The physical exam for menopause includes the standard components — blood pressure, heart rate, weight, BMI — plus a focused gynecologic assessment. The pelvic exam is the part most women dread, but the menopause pelvic exam is usually shorter and less uncomfortable than a routine Pap smear if you are not having active vaginal symptoms. The doctor will visually inspect the vulva and vaginal opening for signs of atrophy: thinning tissue, loss of labial fat pad, pallor, or fissuring. A speculum is then inserted to examine the vaginal walls — the hallmark of GSM on exam is pale, thin, non-rugated vaginal tissue that bleeds easily with speculum insertion. A bimanual exam assesses the uterus and ovaries for size, shape, and tenderness.
The Pap smear schedule for menopausal women has changed. ACOG now recommends cervical cancer screening every 5 years with HPV co-testing through age 65 for women with normal results. Women over 65 who have had adequate prior screening can stop Pap smears altogether. This means many menopause visits do not require a Pap smear at all — and if you are due, you can schedule it separately rather than combining it with the menopause consultation. The ACOG 2024 practice bulletin clarified that “cervical cancer screening should not be a barrier to initiating a discussion about menopause management.” If a practice tells you need a Pap smear before they will discuss HRT, ask why. The two are unrelated.
Breast exam is part of the standard women’s health physical, though the evidence for clinical breast exam in asymptomatic women is weak. The USPSTF gives clinical breast exam a “C” grade — meaning there is at least moderate certainty that the net benefit is small. Mammogram screening is more important. Women over 40 should have an annual or biennial mammogram depending on risk factors. If you are overdue for a mammogram, your menopause visit is a good time to schedule one, but the lack of a recent mammogram should not prevent your doctor from prescribing HRT if you are an appropriate candidate. The understanding menopause stages guide includes a pre-visit checklist that covers all the screening tests that should be current before the exam.
Blood Tests Your Doctor Should Order
The menopause blood panel is simple and targeted. FSH level above 30 IU/L confirms menopause in a woman who has not had a period for 12 months, but the single FSH value is unreliable during perimenopause, when levels fluctuate wildly. Estradiol level is useful for establishing a baseline before starting HRT, though a single value captures only one point in time. Most guidelines recommend against using FSH or estradiol alone to diagnose menopause in women over 45 with classic symptoms — the diagnosis is clinical, based on menstrual history and symptoms. The tests are primarily for baseline monitoring, not diagnosis.
Thyroid function testing is mandatory. Hypothyroidism affects 10 to 15 percent of women in the menopausal age range, and the symptoms — fatigue, weight gain, brain fog, cold intolerance — overlap almost completely with menopause. A 2024 University of Michigan study found that 14 percent of women presenting for a first menopause visit had undiagnosed subclinical hypothyroidism. TSH is the screening test. If TSH is elevated, add free T4. If TSH is borderline (2.5 to 4.0), repeat in 6 weeks. Starting HRT while undiagnosed hypothyroidism exists will leave you with ongoing fatigue and brain fog, and you will blame the HRT when the real problem is your thyroid.
Vitamin D level is a third test that matters for menopause bone health. The 2025 Endocrine Society guideline recommends screening postmenopausal women at risk for vitamin D deficiency. In practice, about 40 percent of postmenopausal women in the US have insufficient 25-hydroxyvitamin D levels (below 30 ng/mL). Correcting vitamin D deficiency before or alongside HRT optimizes bone density response. A 2025 study in The Journal of Bone and Mineral Research found that women who started HRT with vitamin D levels above 30 ng/mL had a 14 percent greater gain in lumbar spine bone density at 12 months than women with levels below 20 ng/mL. The blood draw adds 10 minutes to your visit. The menopause symptoms guide includes a lab test reference table with normal ranges and interpretation guidance.
Bone Density Testing: Who Needs It and When
The DEXA scan — dual-energy X-ray absorptiometry — measures bone mineral density at the hip and lumbar spine. It is the gold standard for osteoporosis screening and is essential before starting any bone-protective treatment. ACOG and NAMS recommend a baseline DEXA for all women at menopause if they have risk factors: low body weight (BMI under 21), personal history of fracture as an adult, family history of hip fracture, smoking, excessive alcohol use, or use of medications that cause bone loss (glucocorticoids, aromatase inhibitors, some antidepressants). For women without these risk factors, ACOG recommends starting screening at age 65.
The DEXA result is reported as a T-score: the number of standard deviations above or below the average bone density of a healthy 30-year-old woman. A T-score above -1.0 is normal. Between -1.0 and -2.5 is osteopenia — low bone mass that warrants monitoring but not necessarily pharmacologic treatment. Below -2.5 is osteoporosis, which requires treatment regardless of other risk factors. The 2024 ISCD (International Society for Clinical Densitometry) official position updated the monitoring interval: women with normal bone density at menopause can wait 10 to 15 years before repeat scanning. Women with osteopenia should repeat every 2 to 5 years depending on the degree of bone loss and the rate of change.
If your DEXA shows osteopenia or osteoporosis, and you are an appropriate candidate for HRT, this becomes a strong secondary indication for starting estrogen therapy. No medication — not even bisphosphonates — outperforms estrogen for bone density preservation when started near menopause. The 2024 ACOG practice bulletin on osteoporosis states that “estrogen therapy is the most effective antiresorptive agent available for women within 10 years of menopause.” If you cannot take HRT, the alternative paths are bisphosphonates (alendronate, risedronate), raloxifene (a SERM), denosumab, or teriparatide for severe cases. The complete guide to menopause treatment options includes a bone health section that walks through the DEXA results and treatment thresholds in plain language.
Eleven Questions You Should Ask During Your Menopause Visit
A good menopause visit is a conversation, not a monologue. The doctor should ask you questions, but you should have your own list ready. Based on the NAMS 2025 patient encounter checklist and input from practicing menopause specialists, these are the 11 questions that extract the most useful information from your appointment.
1. Am I in perimenopause or menopause? — sounds basic, but many doctors conflate the two. The distinction changes treatment options. 2. Do my symptoms fit menopause or could something else be causing them? — thyroid, depression, and anemia all mimic menopause. 3. What are the specific risks for someone with my medical history if I take HRT? — not generic risks, but your personal numbers. 4. If we start HRT, how will we know it’s working and when do I come back for a follow-up? — a clear schedule matters. 5. What is the lowest dose that typically controls symptoms at my stage? — start low is the rule. 6. Is there a non-hormonal option that might work as well for my specific symptoms? — know all your options before choosing. 7. What side effects should I expect in the first month and which ones mean I need to call? — chest pain, leg swelling, and severe headache require calls.
8. Do I need a bone density scan and when? — the answer guides your treatment timeline. 9. What are my options if I have vaginal dryness but do not want systemic treatment? — separate the local from the systemic decisions. 10. Are there lifestyle changes that would reduce my symptoms by enough that I might not need medication? — weight loss, exercise, trigger avoidance. 11. What is your personal experience treating women in menopause? — if the answer is vague, find another doctor. Dr. Jen Gunter, author of “The Menopause Manifesto,” said in a 2025 podcast: “The hallmark of a good menopause visit is that you learn more than the doctor does. If you walk out of that room and you cannot explain your treatment plan to a friend in under a minute, the visit failed.” The complete guide to menopause treatment options has a printable version of this question list that you can bring to your appointment.